Home › NDC Lookup › RxCUI directory › RxCUI 903843

Pyridostigmine bromide 12 MG/ML Oral Solution — RxCUI 903843

RxNorm drug concept · Semantic clinical drug
RxCUI 903843 Semantic clinical drug · SCD ● Current RxNorm concept 10 FDA products 10 package NDCs Snapshot Jul 14, 2026

This page is curated, coded, and maintained by

Compiled from public NLM RxNorm and FDA (openFDA NDC directory) data sources. Editorial policy

What you’re looking at: the standardized identity of one medicine, as the U.S. drug-data system sees it. Below — every FDA-listed product, package code, price benchmark, and billing code that maps to it.

🗂️ Key Facts

RxCUI903843
Official namePyridostigmine bromide 12 MG/ML Oral Solution
Concept typeSemantic clinical drug (SCD)
RxNorm statusCurrent RxNorm concept
Also known aspyridostigmine bromide 60 MG per 5 ML Oral Solution; pyRIDostigmine bromide 60 MG in 5 mL Oral Solution
FDA products mapped10
Package NDCs mapped10
Reported Medicaid activity (SDUD)3,861 prescriptions · 20 state & territory Medicaid programs · latest period Q4 2025
RxNorm release07/06/2026
Snapshot dataJul 14, 2026

📖 Skip the Codes — Read It in Plain English.

Our pharmacist-built guide to Pyridostigmine: what it is, how it’s used, side effects, and interactions.

📗 Our plain-language guide HelloPharmacist
  • Think of it as a protective shield you put up before a threat arrives. Pyridostigmine temporarily occupies key spots on an enzyme in your body that soman would otherwise permanentl...
  • What exactly is pyridostigmine supposed to do for me — does it actually stop soman from hurting me?
  • Timing is everything with this medication. It needs to be started at least several hours before any anticipated exposure — not when an alarm goes off. If you take it immediately be...
  • Does it matter when I take it? Can I just take it right before a threat?
📖 Read our full Pyridostigmine guide →

🕸️ Concept Web — How Pyridostigmine bromide 12 MG/ML Oral Solution Connects

One RxCUI never lives alone. Follow the path from the raw ingredient down to the exact strength-and-form concepts FDA products carry — every stop is a real RxNorm concept with its own identifier. Hover or focus any chip for what it means.
This page's concept Pyridostigmine bromide 12 MG/ML Oral Solution RxCUI 903843

Every web starts here: one RxCUI, one fixed meaning in the RxNorm vocabulary.

  1. Ingredients 2

    The active substance itself — no strength, form, or brand attached yet.

    • Pyridostigmine 9000
    • Pyridostigmine bromide 9001
  2. Brand names 1

    The same medicine's trade names. A brand name alone says nothing about strength or form.

    • Mestinon 203001
  3. Dose forms 13

    The ingredient poured into a form — tablet, solution, cream — still without one fixed strength.

    • Pyridostigmine Oral Solution 756776
    • Pyridostigmine bromide Oral Solution 2647816
    • Pyridostigmine Oral Liquid Product 1163605
    • Pyridostigmine Oral Product 1163606
    • Pyridostigmine bromide Oral Liquid Product 2662437
    • Pyridostigmine bromide Oral Product 2659335
    • Pyridostigmine Oral Solution [Mestinon] 756777
    • Pyridostigmine bromide Oral Solution [Mestinon] 2656874
    • +5 more in this family
  4. Clinical & branded drugs 3

    Ingredient + strength + dose form. These are the concepts real FDA products actually carry.

Showing up to 8 concepts per family — 14 of 19 stored related concepts drawn.
These are official RxNorm vocabulary relationships — how concepts name and organize the same medicine. They do not establish therapeutic equivalence or substitutability: two concepts appearing in one web is never a statement that products can be swapped.

🔀 Generic ⇄ Brand Crosswalk

The same medicine has an unbranded (generic) identity and one or more brand-name identities — each with its own RxCUI. This is a naming relationship in RxNorm, not a statement that any two products are substitutable.

Generic (Clinical) Concepts

  • Pyridostigmine bromide 12 MG/ML SCDC · 903842
  • Pyridostigmine Oral Solution SCDF · 756776
  • Pyridostigmine bromide Oral Solution SCDFP · 2647816
  • Pyridostigmine Oral Liquid Product SCDG · 1163605
  • Pyridostigmine Oral Product SCDG · 1163606
  • Pyridostigmine bromide Oral Liquid Product SCDGP · 2662437
  • Pyridostigmine bromide Oral Product SCDGP · 2659335

Brand-Name Concepts

  • Pyridostigmine bromide 12 MG/ML Oral Solution [Mestinon] SBD · 903845
  • Pyridostigmine bromide 12 MG/ML [Mestinon] SBDC · 903844
  • Pyridostigmine Oral Solution [Mestinon] SBDF · 756777
  • Pyridostigmine bromide Oral Solution [Mestinon] SBDFP · 2656874
  • Mestinon Oral Liquid Product SBDG · 1185041
  • Mestinon Oral Product SBDG · 1185042
  • Mestinon BN · 203001

📦 FDA Products & Package NDCs

10 products · 10 package NDCs
10 package NDCs map to RxCUI 903843 in the current snapshot — up to 50 per page. Each linked NDC opens its full package page.
Package NDC Package Brand / generic name Labeler Marketing start
00187-3010-30 100 TABLET in 1 BOTTLE (0187-3010-30) Mestinon Bausch Health US, LLC 1995-04-06
00187-3012-20 473 mL in 1 BOTTLE (0187-3012-20) Mestinon Bausch Health US, LLC 1965-01-25
00187-3013-30 30 TABLET, EXTENDED RELEASE in 1 BOTTLE (0187-3013-30) Mestinon Bausch Health US, LLC 1959-01-12
16571-0833-16 473 mL in 1 BOTTLE, PLASTIC (16571-833-16) Pryidostigmine Bromide Rising Pharma Holdings, Inc. 2022-09-15
24689-0104-01 473 mL in 1 BOTTLE, PLASTIC (24689-104-01) PRYIDOSTIGMINE BROMIDE Apnar Pharma LP 2024-06-01
66689-0406-10 1 TRAY in 1 CASE (66689-406-10) / 10 CUP, UNIT-DOSE in 1 TR... Pyridostigmine Bromide VistaPharm, LLC 2020-01-06
68682-0307-05 473 mL in 1 BOTTLE (68682-307-05) pyridostigmine bromide Oceanside Pharmaceuticals 2019-07-01
69238-1731-02 473 mL in 1 BOTTLE (69238-1731-2) Pyridostigmine Bromide Amneal Pharmaceuticals NY LLC 2020-01-17
70954-0148-10 473 mL in 1 BOTTLE (70954-148-10) Pyridostigmine Novitium Pharma LLC 2019-03-11
72205-0098-72 473 mL in 1 BOTTLE (72205-098-72) Pyridostigmine Bromide Novadoz Pharmaceuticals LLC 2023-09-26
Observed labelers: Bausch Health US, LLC (3) · Amneal Pharmaceuticals NY LLC (1) · Apnar Pharma LP (1) · Novadoz Pharmaceuticals LLC (1) · Novitium Pharma LLC (1) · Oceanside Pharmaceuticals (1) · +2 more — this is the FDA-listed mapping footprint, not sales, inventory, availability, or market share.

🗃️ Sources & Limits

Atlas generation902fddb9-e9c1-4004-bf4c-dba4d51037c7
openFDA export observedJul 14, 2026
RxNorm release07/06/2026
Methodology2026-07-full-catalog-v1
  • A shared RxCUI does not prove interchangeability. Products mapped to the same concept are not thereby equivalent or substitutable — equivalence is a separate, product-level determination.
  • Listing here does not establish approval or coverage. Appearing in this snapshot is a data observation, not an FDA approval status or a payer coverage decision.
  • Missing data never means zero. A silent dataset (no price, no billing code, no utilization) means no observation — not that the real-world value is zero.
  • Counts describe the mapping footprint. Product, package, and labeler counts are the FDA-listed mapping footprint in this snapshot — not sales, inventory, availability, or market share.
This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product.

Machine-readable JSON

Reference information about drug-concept identifiers and public regulatory data — not medical advice. Talk to your pharmacist or prescriber about your own medication.